Microcapsule Wall Containing Two Or More Layers Patents (Class 264/4.32)
-
Patent number: 6828025Abstract: A process for encapsulation of polar organic solvents with amphiphilic copolymer shell using controlled/living polymerization is provided for the first time. To encapsulate polar core-oils an amphiphilic polymer is required that has low interfacial tensions with both the oil phase and the water phase. For example, Poly(methyl methacrylate-co-poly(ethylene glycol) methacrylate) (PMMA-co-PegMA) was prepared in suspension polymerization conditions using atom transfer radical polymerization (ATRP). ATRP ensures that the water soluble comonomer, PegMA, is incorporated into every polymer chain throughout the polymerization reaction so that all chains possess the desired amphiphilic character. Crosslinking of PMMA-co-PegMA with diethylene glycol dimethacrylate (DegDMA) yielded hollow capsular particles at 31 mol % PegMA in the terpolymer.Type: GrantFiled: May 27, 2003Date of Patent: December 7, 2004Assignee: McMaster UniversityInventors: Mir Mukkaram Ali, Harald D. H. Stöver
-
Publication number: 20040169299Abstract: The present invention is directed to a method for producing macrocapsules containing therein a plurality of microcapsules. In accordance with some embodiments of the present invention, the microcapsules contain a phase change material.Type: ApplicationFiled: March 8, 2004Publication date: September 2, 2004Inventors: Danny Allen Davis, Ronald Lee Hart, Dale Ellis Work, David Russell Virgallito
-
Patent number: 6767483Abstract: Inorganic-organic hybrid mixture sol-gel encapsulated lipid vesicles which are composed of silyl lipids or a mixture of silyl lipids and phospholipids are provided. The present invention also provides encapsulated Langmuir Blogget (LB) membranes and biological macromolecules. The sol-gel encapsulated lipid vesicles, LB membranes and proteins possess a higher stability than conventional vesicles. Inorganic-organic hybrid mixture sol-gels are provided as novel sol-gel materials possessing desirable mechanical and physicochemical properties. Also provided are methods of preparing encapsulated lipid vesicles, LB membranes and proteins. Methods of performing renal dialysis using compositions of the invention are also provided.Type: GrantFiled: August 21, 2001Date of Patent: July 27, 2004Assignee: California Institute of TechnologyInventors: Michael H. B. Stowell, Guangyang Wang, Sunney I. Chan
-
Publication number: 20040084791Abstract: The present invention relates to biodegradable polyurethane capsules for molded product of polyurethane foam and to methods for manufacturing the same, the inventive biodegradable polyurethane capsule comprises a powder made from a biodegradable material, first coating layer of calcium alginate gel formed on the surface of said power and second coating layer of foamable polyurethane resin formed on the surface of said first coating layer. Products manufactured from the biodegradable polyurethane capsule according to the present invention can be widely used as heat isolating materials and heat isolating structural materials because the basic physical properties such as heat insulation are good.Type: ApplicationFiled: December 29, 2003Publication date: May 6, 2004Inventors: Kyu-Tek Han, Jung-Hoon Choi, In-Gyu Lee, lk-Soo Chung
-
Patent number: 6696090Abstract: A method and a process are disclosed for preparation of medical electro-powders. The electro-powder results from preparations of chemical and biological substances to form electro-powders suitable for electrostatic charging and dosing for functionality in a dry powder inhaler device. The electro-powder resulting from the method and process forms an active powder substance or a dry powder medical formulation with a fine particle fraction representing of the order 50% or more of the content having a size ranging between 0.5-5 &mgr;m and provides electrostatic properties with an absolute specific charge per mass after charging of the order 0.1×10−6 to 25×10−6 C/g and presenting a charge decay rate constant Q50>0.1 sec with a tap density of less than 0.8 g/ml and a water activity aw of less than 0.5.Type: GrantFiled: August 11, 2000Date of Patent: February 24, 2004Assignee: Microdrug AGInventors: Thomas Nilsson, Lars-Gunnar Nilsson
-
Patent number: 6676964Abstract: Microcapsules prepared by encapsulating an aqueous solution of a protein, drug or other bioactive substance inside a semi-permeable membrane by are disclosed. The microcapsules are formed by interfacial coacervation under conditions where the shear forces are limited to 0-100 dynes/cm2 at the interface. By placing the microcapsules in a high osmotic dewatering solution, the protein solution is gradually made saturated and then supersaturated, and the controlled nucleation and crystallization of the protein is achieved. The crystal-filled microcapsules prepared by this method can be conveniently harvested and stored while keeping the encapsulated crystals in essentially pristine condition due to the rugged, protective membrane. Because the membrane components themselves are x-ray transparent, large crystal-containing microcapsules can be individually selected, mounted in x-ray capillary tubes and subjected to high energy x-ray diffraction studies to determine the 3-D structure of the protein molecules.Type: GrantFiled: January 26, 2001Date of Patent: January 13, 2004Assignee: The United States of America as represented by the National Aeronautics and Space AdministrationInventors: Dennis R. Morrison, Benjamin Mosier
-
Patent number: 6548170Abstract: The present invention relates to water-insoluble solid particles, especially pigments, which characteristically are coated with at least one layer of at least one product resulting from the reaction between at least one molecule capable of becoming hydrated in contact with water and at least one lipophilic molecule. It further relates to cosmetic, pharmaceutical and agricultural compositions comprising such particles and to the manufacture and use of said particles.Type: GrantFiled: July 19, 2001Date of Patent: April 15, 2003Assignee: ColeticaInventors: Eric Perrier, Lysiane Tholon, Nabil Abdul Malak
-
Patent number: 6544646Abstract: A microcapsule composition comprising a core material in a matrix of polymorphic shell material, releases said core material in an aqueous environment in accordance with zero order linear release profile. A preferred composition comprises a core material having a degree of water solubility entrapped in a beta crystalline matrix of water insoluble shell material which matrix may, optionally, be surrounded by a contiguous core material-free layer of water insoluble shell material. Also disclosed is a process for the preparation of microcapsules comprising subjecting a flowable mixture of core material and a first amount of water insoluble shell material to a pressure force to form a pressure-treated mixture, and passing said pressure-treated mixture through a spray nozzle into a chilling zone to form a solidified composition.Type: GrantFiled: April 27, 2001Date of Patent: April 8, 2003Assignee: Verion Inc.Inventors: Farid Vaghefi, Jeffry Lee, Vijendra Nalamothu
-
Patent number: 6544926Abstract: Dual shell microcapsule aggregate particles and copy materials coated therewith, such aggregate particles having inner shells surrounding chromogenic nucleus material, and outer shells encompassing multiple such inner shells to form aggregate particles thereof. The inner shells are derived from polar pre-polymer compositions. The outer shells are derived from complex colloids such as gelatin and gelatin derivatives. The outer shell material causes agglomeration of the inner shells into aggregate particles, thus increasing the sizes of the particles without increasing the sizes of the respective inner-shell microcapsules which contain the chromogenic material.Type: GrantFiled: October 11, 2001Date of Patent: April 8, 2003Assignee: Appleton Papers Inc.Inventors: Jerome Robert Bodmer, Chandrakant Bhailalbhai Patel, Troy Ronald Seehafer, Todd Arlin Schwantes
-
Patent number: 6514439Abstract: Microcapsules of a microcapsule formed of a polyurea shell wall and an encapsulated ingredient or ingredients enclosed within the wall, the wall comprising at least one oligomeric acetal having the moiety in which R is (a) a moiety containing a chain of from 5 to about 40 optionally substituted carbon atoms, (b) a moiety containing a chain of from 4 to about 40 carbon atoms and one or more internally linked oxygen or sulfur atoms or —NH-groups, or (c) an optionally substituted ethylene or propylene moiety Z is (a) an optionally substituted phenyl group, (b) an optionally substituted C1-C20 alkyl, C2-C20 alkenyl, C3-C8 cycloalkyl or C5-C8 cycloalkenyl group, or (c) benzoyl, and n is 1 if R is (a) or (b), or is 2-20 if R is (c).Type: GrantFiled: December 11, 2001Date of Patent: February 4, 2003Assignee: Syngenta Ltd.Inventors: Juanita E. Van Koppenhagen, Herbert B. Scher, Kuo-shin Lee, Ian M. Shirley, Philip Wade, Richard Follows
-
Patent number: 6284163Abstract: Inorganic-organic hybrid mixture sol-gel encapsulated lipid vesicles which are composed of silyl lipids or a mixture of silyl lipids and phospholipids are provided. The present invention also provides encapsulated Langmuir Blogget (LB) membranes and biological macromolecules. The sol-gel encapsulated lipid vesicles, LB membranes and proteins possess a higher stability than conventional vesicles. Inorganic-organic hybrid mixture sol-gels are provided as novel sol-gel materials possessing desirable mechanical and physicochemical properties. Also provided are methods of preparing encapsulated lipid vesicles, LB membranes and proteins. Methods of performing renal dialysis using compositions of the invention are also provided.Type: GrantFiled: January 24, 1997Date of Patent: September 4, 2001Assignee: California Institute of TechnologyInventors: Michael H. B. Stowell, Guangyang Wang, Sunney I. Chan
-
Patent number: 6242230Abstract: Oxalate-degrading enzymes and bacteria were encapsulated for both enteric and intraperitoneal administration. We have shown that via alginate microencapsulation of Oxalobacter formigenes, enzymatic activity was retained for several months. A new process was developed which strengthened the alginate microcapsules and their tolerance to citrate treatment. Much smaller (30-50 &mgr;m) alginate microcapsules were made for injection as means of implantation. For oral administration, multi-encapsulated microspheres of cellulose acetate phthalate in poly-2-vinylpyridine (pKa=3.5) were prepared to protect the enzymes from gastric juices.Type: GrantFiled: November 18, 1999Date of Patent: June 5, 2001Assignee: University of FloridaInventors: Chris Batich, Farid Vaghefi
-
Patent number: 6171647Abstract: The invention relates to gel-coated microcapsules which have improved mechanical stress- and flame-resistance. A method for making the gel coated microcapsules is also provided. Phase change materials can be included in the microcapsules to provide thermal control in a wide variety of environments.Type: GrantFiled: January 14, 2000Date of Patent: January 9, 2001Assignee: Frisby Technologies, Inc.Inventor: Mark E. Holman